LYEL
Price
$2.74
Change
-$0.05 (-1.79%)
Updated
May 17, 6:59 PM EST
82 days until earnings call
NTLA
Price
$26.22
Change
+$0.05 (+0.19%)
Updated
May 17, 6:59 PM EST
75 days until earnings call
Ad is loading...

LYEL vs NTLA

Header iconLYEL vs NTLA Comparison
Open Charts LYEL vs NTLABanner chart's image
Lyell Immunopharma
Price$2.74
Change-$0.05 (-1.79%)
Volume$885.75K
CapitalizationN/A
Intellia Therapeutics
Price$26.22
Change+$0.05 (+0.19%)
Volume$694.38K
CapitalizationN/A
View a ticker or compare two or three
LYEL vs NTLA Comparison Chart

Loading...

LYELDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NTLADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
LYEL vs. NTLA commentary
May 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a StrongBuy and NTLA is a Hold.

COMPARISON
Comparison
May 18, 2024
Stock price -- (LYEL: $2.78 vs. NTLA: $26.22)
Brand notoriety: LYEL and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 75% vs. NTLA: 85%
Market capitalization -- LYEL: $698.53M vs. NTLA: $2.53B
LYEL [@Biotechnology] is valued at $698.53M. NTLA’s [@Biotechnology] market capitalization is $2.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $593.52B to $0. The average market capitalization across the [@Biotechnology] industry is $2.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 0 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 0 green, 5 red.
According to our system of comparison, NTLA is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 6 TA indicator(s) are bullish while NTLA’s TA Score has 6 bullish TA indicator(s).

  • LYEL’s TA Score: 6 bullish, 4 bearish.
  • NTLA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both LYEL and NTLA are a good buy in the short-term.

Price Growth

LYEL (@Biotechnology) experienced а +3.73% price change this week, while NTLA (@Biotechnology) price change was +7.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.81%. For the same industry, the average monthly price growth was +4.40%, and the average quarterly price growth was +61.33%.

Reported Earning Dates

LYEL is expected to report earnings on Aug 07, 2024.

NTLA is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (+2.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for LYEL with price predictions.
OPEN
A.I.dvisor published
a Summary for NTLA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
NTLA($2.53B) has a higher market cap than LYEL($699M). LYEL YTD gains are higher at: 43.299 vs. NTLA (-14.005).
LYELNTLALYEL / NTLA
Capitalization699M2.53B28%
EBITDAN/AN/A-
Gain YTD43.299-14.005-309%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYELNTLA
RSI
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 23 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
LYELDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NTLADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HDVIX12.58-0.01
-0.08%
Hartford International Equity I
CUHIX10.34-0.02
-0.19%
Victory US 500 Enh Vol Wtd Idx I
VYSEX15.24-0.03
-0.20%
Voya Small Company R6
JVAAX38.19-0.11
-0.29%
JPMorgan Value Advantage A
TWQAX14.13-0.05
-0.35%
Transamerica Large Cap Value A

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with NTLA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
+6.51%
NTLA - LYEL
51%
Loosely correlated
-0.19%
ADPT - LYEL
50%
Loosely correlated
-4.62%
NRIX - LYEL
46%
Loosely correlated
-3.14%
VCYT - LYEL
46%
Loosely correlated
-0.64%
RLAY - LYEL
43%
Loosely correlated
-4.19%
More